Healthcare Private Equity Case Studies | Physician Growth Partners

Market Research

Veterinary Private Equity – Market Update

Winter 2024 COMING SOON IN MARCH 2024

Nephrology Private Equity – Market Update

Winter 2024 COMING SOON IN MARCH 2024

Women’s Health Private Equity – Market Update

Winter 2024 Despite ongoing global economic challenges and macroeconomic headwinds facing the healthcare industry, the women’s health sector continues to remain active as private equity continues to...

Oral Surgery & Specialty Dental Private Equity – Market Update

Winter 2024 Over the past year, the landscape of oral surgery has undergone a dynamic transformation, emerging as a focal point for many leading healthcare focused private...

Pediatrics Private Equity – Market Update

Fall 2023 In the ever-changing healthcare landscape, private equity investors are increasingly turning their attention to the pediatrics sector. Several key market tailwinds are driving this trend....

Plastic Surgery Private Equity – Market Update

Fall 2023 Private equity interest in the plastic surgery space is witnessing an impressive, rapid, and growing surge of interest. Beginning with Prime Plastic Surgery in December...

Pain Management Private Equity – Market Update

Fall 2023 Pain management has been a slow and steady consolidator of physician practices over the last eight years. The specialty has seen less consolidation than other...

Medical Aesthetics Private Equity – Market Update

Fall 2023 While early on from a consolidation standpoint, the medical aesthetics sector continues to draw significant healthcare private equity focus, supported by both favorable demographic tailwinds...

Behavioral Health Private Equity – Market Update

Fall 2023 Traditionally, PE investment in healthcare services has focused on consolidating medical specialties such as dentistry, dermatology, and eye care, with returns driven primarily by multiple...

ENT & Allergy Private Equity – Market Update

Fall 2023 Despite a generally slow healthcare M&A environment in 2023, driven by economic uncertainty and rising interest rates, healthcare private equity investment in the ENT &...

Cardiology Private Equity – Market Update

Fall 2023 The cardiology sector has witnessed significant growth in the last 12 months, drawing substantial interest from private equity investors, particularly as more and more hospital...

Urology Private Equity – Market Update

Fall 2023 As 2023 draws to a close, private equity backed urology groups continues to be active in the urology sector, driven by a confluence of factors...

Eye Care Private Equity – Market Update

Fall 2023 Through the first three quarters of 2023, healthcare private equity transactions in eyecare exhibited a slowdown attributed to a rise in interest rates, an economic...

Orthopedics Private Equity – Market Update

Fall 2023 Private equity investment in orthopedics was initially led by Frazier Healthcare Partners’ HOPCo in 2016 and has seen significant interest over the past several years,...

Dermatology Private Equity – Market Update

Fall 2023 Dermatology remains one of the more mature specialties in terms of consolidation with accelerating investment activity since 2011. Though the early days of consolidation recede...

Gastroenterology Private Equity – Market Update

Fall 2023 Private equity interest in gastroenterology began in 2016 with Audax Group’s formation of Gastro Health. In the years following, eleven additional private equity backed GI...

Primary Care/Multi-Specialty Market Update – Market Update

Spring 2023 In recent years, private equity investors have increasingly been drawn to Primary Care and Multi-Specialty practices. This trend has been driven by a recognition among...

Pediatric Private Equity – Market Update

Spring 2023 The private equity market in the Pediatrics arena is witnessing an impressive surge of interest. Traditionally, private equity firms in the healthcare industry have been...

Cardiology Private Equity – Market Update

Spring 2023 Cardiology consolidation remains in its infancy, but it continues to be one of the hottest sectors attracting interest from private equity. Deal activity is accelerating,...

Medical Aesthetics Private Equity – Market Update

Spring 2023 Following a wave of consolidation across various provider-led healthcare specialties, private equity investors have now targeted the historically overshadowed Medical Aesthetics industry, which includes Medical...

Pain Management Private Equity – White Paper

Winter 2023 Within the landscape of healthcare investing, Pain Management specialty practices have seen amplified levels of interest from private equity investors since 2020. Despite this interest,...

Oral Surgery/Dentistry Private Equity – White Paper

Winter 2023 Dating back to the late 1990s with the inception of Aspen Dental, the dental industry has been a long-time point of interest for private equity...

Primary Care & Multispecialty Private Equity – Market Update

Winter 2023 The Primary Care and Multi-Specialty space continues to see private equity as a new and differentiated strategic option compared to what has been available to...

Private Equity and What It Means for Your Medical Practice – White Paper

Winter 2022 Why you need a knowledgeable transaction advisor in your corner and how to choose the right one The appetite of private equity (PE) investors for...

Eye Care Private Equity – Market Update

Fall 2022 Since 2017 eye care has quickly become one of the largest areas for private equity investment in the entire healthcare market. As of 2022 as...

Behavioral Health Private Equity – Market Update

Fall 2022 Driven by numerous national tailwinds, including reduced stigma and the rise of telehealth, behavioral health has become a highly targeted sector for private equity investment....

Urology Private Equity – Market Update

Fall 2022 In the past three years consolidation within urology has shifted from nascent in nature to a pervasive force across the specialty, and it now serves...

Orthopedic Private Equity – Market Update

Fall 2022 PE interest in Orthopedics has picked up momentum in 2022 with transaction volume increasing. However, these are still the ‘early-innings’ of private equity investment compared...

Dermatology Private Equity – Market Update

Fall 2022 Dermatology saw its first private equity investment in 2011, activity which sparked a decade-long wave of wide-spread, national consolidation in the space. With the early...

Urology Private Equity – Market Update

Summer 2022 In recent years urology has grown as an attractive specialty target for private equity investors. With a historically fragmented landscape, large PE-backed platforms have increased...

Orthopedic Private Equity – White Paper

Spring 2022 Within the landscape of healthcare investing, orthopedic specialty practices have seen amplified levels of interest from private equity investors within the past year. Despite this...

Women’s Health Private Equity – Market Update

Spring 2022 Women’s Health remains a leading area of interest for private equity investment in healthcare. Since initial investment began in 2013 when Unified Women’s Healthcare was...

Cardiology Private Equity – Market Update

Spring 2022 Cardiology is one of the newer sectors seeing interest from private equity and activity is ramping up. We have seen seven new organizations enter this...

Gastroenterology Private Equity – Market Update

Spring 2022 Gastroenterology has emerged as an important sector of interest for private equity investment. Although the market is still in the early stage of consolidation, the...

Gastroenterology Private Equity – White Paper

Fall 2021 Gastroenterology is quickly becoming one of the fastest moving sectors in terms of physician practice consolidation. Beginning in 2016 with Audax’s acquisition of Florida-based Gastro...

Dermatology Private Equity – White Paper

Summer 2021 While private equity is no stranger to dermatology having been invested in the specialty for ~10 years, the opportunity for dermatology practices to partner with...

Pain Management Private Equity – Market Update

Summer 2021 Even with Private Equity investment in Interventional Pain Management (“IPM”) accelerating in recent years, it remains one of the most fragmented areas within subspecialty medicine....

Oral Surgery Private Equity – Market Update

Summer 2021 Private Equity consolidation in Oral Surgery is very new compared to other sectors. There are currently just five active platforms (the first investment from private...

Orthopedics Private Equity – Market Update

Summer 2021 A relatively new sector to experience the wave of private equity investment, orthopedics has begun to show signs of being the next "hot sector." Sharing...

Eye Care Private Equity – Market Update

Summer 2021 Now more than ever, ophthalmologists and optometrists are considering a partnership with Private Equity due to attractive valuations and significant outside economic forces within the...

Dermatology Private Equity – Market Update

Summer 2021 Dermatology saw its first private equity investment in 2011 which sparked a decade-long wave of national consolidation in the space. Most recently, HEP Fund’s partnership...

Primary Care & Multispecialty Private Equity – Market Update

Summer 2021 After many years of Private Equity investments focused on single specialty providers, Primary Care and Multi-specialty have proven to be among the hottest areas for...

Urology Private Equity – White Paper

Summer 2021 While investment in the physician practice management sector is not new, a targeted focus on urology gained traction during 2020 with more than 6 transactions...

Cardiology Private Equity – Market Update

Summer 2021 Cardiology is one of the newer sectors seeing interest from private equity. There are just six notable platforms currently active in the space. Compared to...

Women’s Health Private Equity – Market Update

Spring 2021 Women’s Health is a relatively new sector of interest for private equity groups (the first investment from private equity was Ares partnership with Unified Women’s...

Eye Care Private Equity – White Paper

Spring 2021 Amidst a global pandemic, 2020 saw private equity firms continue to flood the Eye Care sector with attractive alternatives for private practice physicians. Now, more...

Please Reach Out

Thank you for your interest in connecting with PGP. Please reach out to us directly at the number or email below or use this contact form. One of our lead healthcare transaction advisors will be in touch shortly.

432 N. Clark Street, Ste. 200, Chicago, IL 60654

Name(Required)